Abstract
Yersinia pestis, the causative agent of plague, is an extremely virulent bacterium but there are no approved vaccines for protection against it. Our goal was to produce a vaccine that would address: ease of delivery, mucosal efficacy, safety, rapid scalability, and cost. We developed a novel production and delivery system for a plague vaccine of a Y. pestis F1-V antigen fusion protein expressed in tomato. Immunogenicity of the F1-V transgenic tomatoes was confirmed in mice that were primed subcutaneously with bacterially-produced F1-V and boosted orally with transgenic tomato fruit. Expression of the plague antigens in fruit allowed producing an oral vaccine candidate without protein purification and with minimal processing technology.
Original language | English (US) |
---|---|
Pages (from-to) | 2477-2490 |
Number of pages | 14 |
Journal | Vaccine |
Volume | 24 |
Issue number | 14 |
DOIs | |
State | Published - Mar 24 2006 |
Keywords
- Plague vaccine
- Plant-made vaccines
- Tomato
- Transgenic plants
ASJC Scopus subject areas
- Molecular Medicine
- Immunology and Microbiology(all)
- veterinary(all)
- Public Health, Environmental and Occupational Health
- Infectious Diseases